Adaptive Biotechnologies Corporation (ADPT)
NASDAQ·Healthcare·Biotechnology
$14.00
-1.48%
Mkt Cap $2.19B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 5, 2026 | $60.89M | $71.68M | +17.72% | -$0.19 | -$0.09 | +52.63% | — | — |
| Q4 2025 Nov 5, 2025 | $59.38M | $93.97M | +58.25% | -$0.16 | -$0.15 | +6.25% | — | — |
| Q3 2025 Aug 5, 2025 | $55.40M | $58.88M | +6.28% | -$0.24 | -$0.17 | +29.17% | — | — |
| Q2 2025 May 1, 2025 | $42.13M | $52.44M | +24.49% | -$0.28 | -$0.20 | +28.57% | — | — |
| Q1 2025 Feb 11, 2025 | $46.05M | $47.46M | +3.06% | -$0.27 | -$0.23 | +14.81% | — | — |
| Q4 2024 Nov 7, 2024 | $40.21M | $46.44M | +15.48% | -$0.30 | -$0.22 | +26.67% | — | — |
| Q3 2024 Aug 1, 2024 | $40.57M | $43.19M | +6.46% | -$0.32 | -$0.26 | +18.75% | — | — |
| Q2 2024 May 7, 2024 | $38.78M | $41.87M | +7.98% | -$0.35 | -$0.33 | +5.71% | — | — |
| Q1 2024 Feb 14, 2024 | $48.46M | $45.78M | -5.52% | -$0.32 | -$0.30 | +6.25% | — | — |
| Q4 2023 Nov 9, 2023 | $42.96M | $37.92M | -11.73% | -$0.32 | -$0.35 | -9.37% | — | — |
| Q3 2023 Aug 2, 2023 | $44.89M | $48.93M | +8.99% | -$0.33 | -$0.33 | +0.00% | — | — |
| Q2 2023 May 3, 2023 | $36.81M | $37.65M | +2.27% | -$0.34 | -$0.40 | -17.65% | — | — |
| Q1 2023 Feb 14, 2023 | $54.72M | $55.20M | +0.87% | -$0.37 | -$0.28 | +24.32% | — | — |
| Q4 2022 Nov 3, 2022 | $47.81M | $47.83M | +0.04% | -$0.37 | -$0.32 | +13.51% | — | — |
| Q3 2022 Aug 3, 2022 | $41.81M | $43.66M | +4.43% | -$0.40 | -$0.37 | +7.50% | — | — |
| Q2 2022 May 4, 2022 | $37.77M | $38.62M | +2.24% | -$0.43 | -$0.44 | -2.33% | — | — |
| Q1 2022 Feb 15, 2022 | $36.37M | $37.93M | +4.30% | -$0.43 | -$0.43 | +0.00% | — | — |
| Q4 2021 Nov 3, 2021 | $37.07M | $39.47M | +6.47% | -$0.43 | -$0.40 | +6.98% | — | — |
| Q3 2021 Aug 4, 2021 | $31.26M | $38.51M | +23.18% | -$0.43 | -$0.35 | +18.60% | — | — |
| Q2 2021 May 5, 2021 | $27.75M | $38.44M | +38.53% | -$0.41 | -$0.29 | +29.27% | — | — |